Hydroxychloroquine retinopathy Hydroxychloroquine retinopathy
Conditions
Interventions
SITA Standard 24-2,SITA Faster 24-2C
Active Comparator Device,Active Comparator Device
Sponsors
Ratchadapisek Research Funds
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who had been diagnosed with CQ/HCQ retinopathy and those classified as high-risk patients, based on meeting one or more of the following criteria: a CQ dosage exceeding 2.3 mg/kg of real weight, an HCQ dosage exceeding 5 mg/kg of real weight, prolonged usage exceeding beyond 5 years, the presence of kidney disease with a subnormal glomerular filtration rate, or concurrent use of prior tamoxifen use. , were recruited from the ophthalmology clinic at King Chulalongkorn Memorial Hospital. Additional inclusion criteria mandated required that participants be 18 years of age or older and possess a documented history of reliable automated perimetry
Exclusion criteria
Exclusion criteria: unreliable visual fields suboptimal quality SD-OCT, FAF retinopathy, optic neuropathy, or optical media opacities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean deviation Crossectional Visual field index from Humphrey visual field test | — |
Secondary
| Measure | Time frame |
|---|---|
| pattern standard deviation (PSD) crossectional Visual field index | — |
Countries
Thailand
Contacts
Public ContactChananachida Wongwachira
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed